Gideon Morris Hirschfield

30PUBLICATIONS
173CO-AUTHORS
Radiation therapyGastroenterology and hepatologyCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|May 12, 2026
Reply: Fracture risk under selective and non-selective PPAR agonists in primary biliary cholangitis.

|Dec 01, 2025
Fracture events in patients with primary biliary cholangitis during treatment with seladelpar in the phase III RESPONSE trial.

John M Vierling, Gideon M Hirschfield, Robert P Kustra

|Nov 18, 2025
Clinicogenomic Characterization of Primary Sclerosing Cholangitis-Associated Biliary Tract Cancers.

Xin Wang, Jaime Ivan Haro-Silerio, Felix E G Beaudry

|Sep 29, 2025
High biochemical remission rates in patients with primary biliary cholangitis treated with "triple" anticholestatic therapy.

Guilherme G L Cançado, Bo Chen, Madeline Cameron

|Jun 13, 2025
Editorial: Patient Reported Outcomes Provide Insight Into Disease Severity for People Living With Primary Sclerosing Cholangitis.

Aisha Alawi, Gideon M Hirschfield

|Apr 30, 2025
Hepatobiliary complications in patients with sickle cell disease: A 30-year review of 1009 patients.

Maya Deeb, Kristel K Leung, Richard Ward

Pageof 5

Frequent Collaborators

7 joint publications

Palak Trivedi

5 joint publications

Cynthia Levy

5 joint publications

Marlyn Mayo

4 joint publications

Aliya Gulamhusein